Publikationen 2013
Impact of Recommendation Updates in Well-Controlled Patients on Nonrecommended Antiretroviral Therapies and the Swiss HIV Cohort Study
Boillat-Blanco N, Darling KE, Taffe P, Osih R, Strahm C, Adami M, Elzi L, Daou S, Fehr J, Wandeler G, Cavassini M
J Acquir Immune Defic Syndr. 2013 Feb 1
Die peripher venöse Punktion Teil 1: Die therapeutische Venenpunktion
Markus Gnädinger, Christine Widmer, Barbara Schöbi, Hansruedi Stoll, Thomas Schnider, Andreas Huber
Schweiz Med Forum 2013;13(4):70–74
Die peripher venöse Punktion Teil 2: Die therapeutische Venenpunktion
Markus Gnädinger, Christine Widmer, Barbara Schöbi, Hansruedi Stoll, Thomas Schnider, Andreas Huber
Schweiz Med Forum 2013;13(5):94–96
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
Du Pasquier RA, Jilek S, Kalubi M, Yerly S, Fux CA, Gutmann C, Cusini A, Günthard HF, Cavassini M, Vernazza PL and thr Swiss HIV Cohort Study
AIDS. 2013 Jan 14;27(2):203-10
Bacillary Angiomatosis and Bacteremia due to Bartonella quintana in a Patient with Chronic Lymphocytic Leukemia
Rosamaria Fulchini, Guido Bloemberg, Katia Boggian
Case Reports in Infectious DiseasesVolume 2013, Article ID 694765, 4 pages
Efficacy and safety of lersivirine (UK-453,061) versus efavirenz in antiretroviral treatment-naive HIV-1-infected patients: week 48 primary analysis results from an ongoing, multicenter, randomized, double-blind, phase IIb trial.
Vernazza P, Wang C, Pozniak A, Weil E, Pulik P, Cooper DA, Kaplan R, Lazzarin A, Valdez H, Goodrich J, Mori J, Craig C, Tawadrous M
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):171-9
Risk of Cardiovascular Events and Blood Pressure Control in Hypertensive HIV-Infected Patients: Swiss HIV Cohort Study (SHCS)
Nüesch R, Wang Q, Elzi L, Bernasconi E, Weber R, Cavassini M, Vernazza P, Thurnheer MC, Calmy A, Battegay M, Bucher HC; the Swiss HIV Cohort Study
J Acquir Immune Defic Syndr. 2013 Jan 2
Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiative
Rodger AJ, Bruun T, Vernazza P, Collins S, Estrada V, Van Lunzen J, Corbelli GM, Phillips AN, Lundgren JD; PARTNER Study Group
Antivir Ther. 2013;18(3):285-7
Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections–‚triple p in uti‘: study protocol for a randomized controlled trial
Drozdov D, Thomer A, Meili M, Schwarz S, Kouegbe RB, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Reutlinger B, Ottiger C, Buchkremer F, Litke A, Schuetz P, Huber A, Bürgi U, Fux CA, Bock A, Müller B, Albrich WC; Triple P study group
Trials. 2013 Mar 22;14:84
The potential impact of biomarker-guided triage decisions for patients with urinary tract infections
Litke A, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, Schäfer P, Reutlinger B, Mueller B, Albrich WC
Infection. 2013 Feb 24
Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia
Schuetz P, Litke A, Albrich WC, Mueller B
Curr Opin Infect Dis. 2013 Apr;26(2):159-67
Biomarker-enhanced triage in respiratory infections – a proof-of-concept feasibility trial
Albrich WC, Rüegger K, Dusemund F, Schuetz P, Arici B, Litke A, Blum CA, Bossart R, Regez K, Schild U, Guglielmetti M, Conca A, Schäfer P, Schubert M, Geest SD, Reutlinger B, Irani S, Bürgi U, Huber A, Müller B
Eur Respir J. 2013 Apr 18
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich WC; ProREAL Study Team
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):51-60
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Karin J Metzner, Alexandra U Scherrer1, Benjamin Preiswerk, Beda Joos, Viktor von Wyl, Christine Leemann, Philip Rieder, Dominique Braun, Christina Grube, Herbert Kuster, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Hansjakob Furrer, Manuel Battegay, Pietro L Vernazza, Matthias Cavassini, Alexandra Calmy, Enos Bernasconi, Rainer Weber, Huldrych F Günthard, and the Swiss HIV Cohort Study
Journal of Infectious Diseases Advance Access published July 11, 2013
Risk Factors for Anal Cancer in Persons Infected With HIV: A Nested Case-Control Study in the Swiss HIV Cohort Study
Bertisch B, Franceschi S, Lise M, Vernazza P, Keiser O, Schöni-Affolter F, Bouchardy C, Dehler S, Levi F, Jundt G, Ess S, Pawlita M, Kovari H, Wandeler G, Calmy A, Cavassini M, Stöckle M, Clifford G; for the Swiss HIV Cohort Study Investigators
Am J Epidemiol. 2013 Jul 30
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV Cohort Study
Wandeler G, Gsponer T, Bihl F, Bernasconi E, Cavassini M, Kovari H, Schmid P, Battegay M, Calmy A, Egger M, Furrer H, Rauch A; the Swiss HIV Cohort Study
J Infect Dis. 2013 Jul 30
Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Scherrer AU, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Calmy A, Cavassini M, Elzi L, Vernazza PL, Bernasconi E, Ledergerber B, Günthard HF and the Swiss HIV Cohort Study (SHCS)
PLoS One. 2013 Jul 25;8(7)
HIV-infected women in Europe: gender-specific needs and challenges
Barbara Bertisch, Beatriz Grinsztejn, Alexandra Calmy
Antiviral Therapy 24 July 2013
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study
Wang Q, Young J, Bernasconi E, Cavassini M, Vernazza P, Hirschel B, Weber R, Furrer H, Stoeckle M, Bucher HC, Fux C; Swiss HIV Cohort Study
Antivir Ther. 2013;18(3):337-44
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control
Bartha I, Carlson JM, Brumme CJ, McLaren PJ, Brumme ZL, John M, Haas DW, Martinez-Picado J, Dalmau J, López-Galíndez C, Casado C, Rauch A, Günthard HF, Bernasconi E, Vernazza P, Klimkait T, Yerly S, O’Brien SJ, Listgarten J, Pfeifer N, Lippert C, Fusi N, Kutalik Z, Allen TM, Müller V, Harrigan PR, Heckerman D, Telenti A, Fellay J.
Elife. 2013 Oct 29;2
Symptom manageability in Swiss HIV-infected patients
Fierz K, Engberg S, Nicca D, Moody K, Battegay M, Spirig R.
Appl Nurs Res. 2013 Aug26(3):110-5
Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss Transplant Cohort Study
Bucheli E, Kralidis G, Boggian K, Cusini A, Garzoni C, Ma-nuel O, Meylan PR, Mueller NJ, Khanna N, van Delden C, Berger C, Koller MT, Weisser M; the Swiss Transplant Cohort Study
Transpl Infect Dis. 2013 Dec 16
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients
Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, van Delden C, Berger C, Boggian K, Cusini A, Koller MT, Weisser M, Pascual M, Meylan PR; Swiss Transplant Cohort Study
Am J Transplant. 2013 Sep;13(9):2402
HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis
Fenner L, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, Helbling P, Fehr J, Gsponer T, Rieder HL, Zwahlen M, Hoffmann M, Bernasconi E, Cavassini M, Calmy A, Dolina M, Frei R, Janssens JP, Borrell S, Stucki D, Schrenzel J, Böttger EC, Gagneux S; Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups
PLoS Genet. 2013; 9: e1003318
Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera
Achermann Y, Rössle M, Hoffmann M, Deggim V, Kuster S, Zimmermann DR, Bloemberg G, Hombach M, Hasse B
J Clin Microbiol. 2013; 51: 1769-73
MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up
Kohler P, Bregenzer-Witteck A, Rettenmund G, Otterbech S, Schlegel M.Infection. 2013 Feb;41(1):33-40. doi[abstract] [Autors copy]
Presumably hospital-transmitted Clostridium difficile infections based on epidemiological linkage.
Kohler P, Bregenzer-Witteck A, Rafeiner P, Schlegel M.Swiss Med Wkly. 2013 Jul 25;143:w13824. doi[abstract] [Autors copy]
